Oncowitan logo (white)
  • About us
  • Our offer
    • Scientific writing & evaluation
    • Pharma projects
    • CDMO support
  • News
    • CDMO
    • Publications
  • [Gallery]

News-Publications

News-Publications

New publication: Antifungal agents used to treat tea and tobacco leaf spot diseases.

(more…)

By Christian Bailly, 1 month24 May 2026 ago
News-Publications

New publication. The antifungal product wuyiencin: identity and mechanism.

(more…)

By Christian Bailly, 1 month24 May 2026 ago
News-Publications

New publication: Barettin alkaloids from the marine sponge Geodia barretti

(more…)

By Christian Bailly, 3 months13 April 2026 ago
News-Publications

New publication: Pharmacology of the medicinal plant Cipadessa baccifera.

(more…)

By Christian Bailly, 5 months9 February 2026 ago
News-Publications

New publication: Chemistry and pharmacology of naamidine alkaloids.

(more…)

By Christian Bailly, 5 months9 February 2026 ago
News-Publications

New publication: The past, present, and future of the anesthetic drug dyclonine

(more…)

By Christian Bailly, 7 months ago
News-Publications

New publication: The pharmacology of the diketopiperazine natural product cyclo(L-Leu-L-Pro) dissected.

(more…)

By Christian Bailly, 8 months8 November 2025 ago
News-Publications

New publication: An overview of incisterol-type natural products isolated from fungi.

(more…)

By Christian Bailly, 8 months25 October 2025 ago
News-Publications

New publication: An overview of all natural products isolated from the Asian marine sponge Hyrtios erectus and their bioactivities

(more…)

By Christian Bailly, 8 months25 October 2025 ago
News-Publications

New publication: Phytochemical analysis of the medicinal plant Chrysanthemum boreale Makino.

(more…)

By Christian Bailly, 10 months22 August 2025 ago

Posts navigation

1 2 … 10 Next
Search
  • Our partners
  • Contact
  • Legal notice
Hestia | Developed by ThemeIsle
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.